{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:20:01Z","timestamp":1793881201878,"version":"4.7.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T00:00:00Z","timestamp":1539216000000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1093\/ckj\/sfy093","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T15:51:21Z","timestamp":1536162681000},"page":"348-354","source":"Crossref","is-referenced-by-count":16,"title":["Assessment of active tubulointerstitial nephritis in non-scarred renal cortex improves prediction of renal outcomes in patients with IgA nephropathy"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9031-481X","authenticated-orcid":false,"given":"Alastair J","family":"Rankin","sequence":"first","affiliation":[{"name":"Institute of Cardiovascular & Medical Sciences, University of Glasgow, Glasgow, UK"},{"name":"Glasgow Renal & Transplant Unit, Queen Elizabeth University Hospital, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kipgen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Queen Elizabeth University Hospital, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6747-6423","authenticated-orcid":false,"given":"Colin C","family":"Geddes","sequence":"additional","affiliation":[{"name":"Glasgow Renal & Transplant Unit, Queen Elizabeth University Hospital, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan G","family":"Fox","sequence":"additional","affiliation":[{"name":"Glasgow Renal & Transplant Unit, Queen Elizabeth University Hospital, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Milne","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospital Monklands, Airdrie, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Mackinnon","sequence":"additional","affiliation":[{"name":"Glasgow Renal & Transplant Unit, Queen Elizabeth University Hospital, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily P","family":"McQuarrie","sequence":"additional","affiliation":[{"name":"Glasgow Renal & Transplant Unit, Queen Elizabeth University Hospital, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,10,10]]},"reference":[{"key":"2019053109303262400_sfy093-B1","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1056\/NEJMra020109","article-title":"IgA nephropathy","volume":"347","author":"Donadio","year":"2002","journal-title":"N Engl J Med"},{"key":"2019053109303262400_sfy093-B2","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/ki.2009.168","article-title":"The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility","volume":"76","author":"Roberts","year":"2009","journal-title":"Kidney Int"},{"key":"2019053109303262400_sfy093-B3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/ki.2015.322","article-title":"The MEST score provides earlier risk prediction in lgA nephropathy","volume":"89","author":"Barbour","year":"2016","journal-title":"Kidney Int"},{"key":"2019053109303262400_sfy093-B4","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/ki.2009.243","article-title":"The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification","volume":"76","author":"Cattran","year":"2009","journal-title":"Kidney Int"},{"key":"2019053109303262400_sfy093-B5","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1053\/j.ajkd.2013.04.021","article-title":"Evaluation of the oxford classification of IgA nephropathy: a systematic review and meta-analysis","volume":"62","author":"Lv","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"2019053109303262400_sfy093-B6","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/ki.2014.63","article-title":"Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments","volume":"86","author":"Coppo","year":"2014","journal-title":"Kidney Int"},{"key":"2019053109303262400_sfy093-B7","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","article-title":"Oxford classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group","volume":"91","author":"Trimarchi","year":"2017","journal-title":"Kidney Int"},{"key":"2019053109303262400_sfy093-B8","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.2215\/CJN.01170211","article-title":"The use of the oxford classification of IgA nephropathy to predict renal survival","volume":"6","author":"Alamartine","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"2019053109303262400_sfy093-B9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s40620-015-0227-8","article-title":"Prognostic value of endocapillary hypercellularity in IgA nephropathy patients with no immunosuppression","volume":"29","author":"Chakera","year":"2016","journal-title":"J Nephrol"},{"key":"2019053109303262400_sfy093-B10","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1681\/ASN.2016040433","article-title":"A multicenter study of the predictive value of crescents in IgA nephropathy","volume":"28","author":"Haas","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2019053109303262400_sfy093-B11","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"key":"2019053109303262400_sfy093-B12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","article-title":"A guideline of selecting and reporting intraclass correlation coefficients for reliability research","volume":"15","author":"Koo","year":"2016","journal-title":"J Chiropr Med"},{"key":"2019053109303262400_sfy093-B13","first-page":"1","article-title":"KDIGO clinical practice guideline for glomerulonephritis","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"2019053109303262400_sfy093-B14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/sj.ki.5002046","article-title":"Severity of tubulointerstitial inflammation and prognosis in immunoglobulin A nephropathy","volume":"71","author":"Myllym\u00e4ki","year":"2007","journal-title":"Kidney Int"},{"key":"2019053109303262400_sfy093-B15","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1159\/000045087","article-title":"Morphologic high-risk factors in IgA nephropathy","volume":"79","author":"Freese","year":"1998","journal-title":"Nephron"},{"key":"2019053109303262400_sfy093-B16","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1056\/NEJMoa1415463","article-title":"Intensive supportive care plus immunosuppression in IgA nephropathy","volume":"373","author":"Rauen","year":"2015","journal-title":"N Engl J Med"},{"key":"2019053109303262400_sfy093-B17","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jama.2017.9362","article-title":"Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy","volume":"318","author":"Lv","year":"2017","journal-title":"JAMA"},{"key":"2019053109303262400_sfy093-B18","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1093\/ndt\/gfn677","article-title":"Centre variation in incidence, indication and diagnosis of adult native renal biopsy in Scotland","volume":"24","author":"McQuarrie","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"2019053109303262400_sfy093-B19","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1681\/ASN.2014070697","article-title":"Corticosteroids in IgA nephropathy: a retrospective analysis from the VALIGA Study","volume":"26","author":"Tesar","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2019053109303262400_sfy093-B20","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/ndt\/17.6.1081","article-title":"Reproducibility of the Banff schema in reporting protocol biopsies of stable renal allografts","volume":"17","author":"Gough","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"2019053109303262400_sfy093-B21","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/ki.2010.460","article-title":"Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies","volume":"79","author":"El Karoui","year":"2011","journal-title":"Kidney Int"},{"key":"2019053109303262400_sfy093-B22","doi-asserted-by":"crossref","first-page":"e91756","DOI":"10.1371\/journal.pone.0091756","article-title":"Prognosis in IgA nephropathy: 30-year analysis of 1, 012 patients at a single center in Japan","volume":"9","author":"Moriyama","year":"2014","journal-title":"PLoS One"},{"key":"2019053109303262400_sfy093-B23","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.humpath.2013.08.019","article-title":"Comparison of the Haas and the Oxford classifications for prediction of renal outcome in patients with IgA nephropathy","volume":"45","author":"Park","year":"2014","journal-title":"Hum Pathol"},{"key":"2019053109303262400_sfy093-B24","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/modpathol.2013.222","article-title":"Using the Oxford classification of IgA nephropathy to predict long-term outcomes of Henoch\u2013Sch\u00f6nlein purpura nephritis in adults","volume":"27","author":"Ho Kim","year":"2014","journal-title":"Mod Pathol"},{"key":"2019053109303262400_sfy093-B25","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/ndt\/12.11.2277","article-title":"Long-term prognosis of Henoch-Sch\u00f6nlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Sch\u00f6nlein purpura","volume":"12","author":"Coppo","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"2019053109303262400_sfy093-B26","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/01.ASN.0000013883.99976.22","article-title":"Henoch-Sch\u00f6nlein Purpura in adults: outcome and prognostic factors","volume":"13","author":"Pillebout","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"2019053109303262400_sfy093-B27","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3346\/jkms.2014.29.2.198","article-title":"Differences in clinical manifestations and outcomes between adult and child patients with Henoch-Sch\u00f6nlein purpura","volume":"29","author":"Kang","year":"2014","journal-title":"J Korean Med Sci"},{"key":"2019053109303262400_sfy093-B28","first-page":"2066","article-title":"Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure","volume-title":"Am J Transplant","author":"Mannon","year":"2010"},{"key":"2019053109303262400_sfy093-B29","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/ajt.14625","article-title":"The Banff 2017 Kidney Meeting Report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials","volume":"18","author":"Haas","year":"2018","journal-title":"Am J Transplant"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ckj\/article-pdf\/12\/3\/348\/28752503\/sfy093.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T09:30:46Z","timestamp":1559295046000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/12\/3\/348\/5126407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,10]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,10,10]]},"published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfy093","relation":{},"ISSN":["2048-8513"],"issn-type":[{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6]]},"published":{"date-parts":[[2018,10,10]]}}}